LAGUNA HILLS, Calif.–(BUSINESS WIRE)– #INDstatus–PharmaCyte Biotech announces its IND submission to the FDA for its clinical trial in locally advanced, inoperable pancreatic cancer.
News Ticker
- [ October 7, 2026 ] Research Assistant (Center for Neurobehavioral Genetics) – Los Angeles, CA 90095 Los Angeles Biotech Jobs
- [ October 7, 2026 ] Childhood abuse leaves a scar on the brain, UCLA study finds Los Angeles Biotech News
- [ October 6, 2026 ] Envista Schedules Third Quarter 2026 Earnings Call Los Angeles Biotech News
- [ October 6, 2026 ] WesternU College of Podiatric Medicine to expand virtual reality learning modules and financial aid with gifts from Dr. Bruce Lawrence and Mrs. Janet Lawrence Los Angeles Biotech News
- [ October 6, 2026 ] Ritual Launches Creatine Greens, a 3-in-1 daily drink for muscle and metabolic health* Los Angeles Biotech News
Copyright © 2026 Biotech Networks, LLC
